MedTrace Logo

Increasing the Impact of a School Prevention Program Among Young Adolescents by Adding a Teacher Component

NCT05102526 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2021-11-01

No results posted yet for this study

Summary

A randomized clinical trial in clusters, including the development and implementation of an intervention program among young adolescents and their teachers. The research hypothesis is that the intervention program will yield improvement in adolescents whose parents participated in the program, compared with adolescents whose teachers were not involved in the intervention. The results will be measured using the research questionnaire, which participants will complete before, after and three months after the end of the program. The questionnaire will include approved questionnaires with good psychometric properties. In addition, there will be a quality interview. The study protocol was approved by the Tel Hai College Institutional Audit Committee. Parents of all participants in the intervention and control group as well as the teachers involved in the program received information about the program and research and were asked to give informed consent.

Conditions

  • Primary Prevention

Interventions

BEHAVIORAL

Experimental: "Young Millie" prevention program, active teachers

Prevention program: "Young Mili", in collaboration with the teacher

BEHAVIORAL

Prevention program: "Young Mili", non active teachers

Prevention program: "Young Mili", without the participation of the teacher

Sponsors & Collaborators

  • Tel Hai College

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-01
Primary Completion
2022-12-01
Completion
2023-10-01

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05102526 on ClinicalTrials.gov